Target Biotech V Net Worth & Insider Trades
Target Biotech V Esperion Therapeutics, Inc
What is Target Biotech V's Net Worth?
The current estimated net worth of Esperion Therapeutics, Inc's Target Biotech V is estimated to be about $105.07M . Target Biotech V owns about 4,477,964 units of Esperion Therapeutics, Inc common stock. In the last 3 years at Esperion Therapeutics, Inc, Target Biotech V has sold an estimated value of $0 worth.
What is Target Biotech V's Past Insider Trading?
Target Biotech V's largest purchase order was 130,000 units , worth over $5.21M on May 22, 2018. In total, Target Biotech V has made about 16 transactions over 3 years of their time at Esperion Therapeutics, Inc. Target Biotech V usually trades in May, with the busiest year in 2018. The most recent transaction was a purchase order of 100,000 units , worth over $2.02M on May 26, 2021.
TARGET BIOTECH V, AG BIOTECH BB
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Target Biotech V's' Mailing Address?
- Mailing address is Ara Hill Top Building, Unit A-5 Pletterijweg Oost 1, Curacao Willemstad P8 000000 Netherlands Antilles
What are Esperion Therapeutics, Inc's Past Insider Trades?
Esperion Therapeutics, Inc's most recent insider trade came on March 20, 2023 by Joanne Foody who sold 3,808 units worth $6.79K . In the last 10 years, insiders at Esperion Therapeutics, Inc have sold an estimated value of $198.32M and bought an estimated value of $137.47M worth of shares. Insider trading is most common in May, with the busiest year in 2018. The most active traders at the company are Timothy Mayleben, President & CEO, Ag Biotech Bb, and Target Biotech V .
Esperion Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||